Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop - ScienceDirect
EGFR involved in tumorigenesis of non-small-cell lung cancer. Akt =... | Download Scientific Diagram
Gene Mutations in Lung Cancer: Promising Predictive Factors for the Success of Molecular Therapy | PLOS Medicine
Cancers | Free Full-Text | Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies
IJMS | Free Full-Text | Molecular Epidemiology of the Main Druggable Genetic Alterations in Non-Small Cell Lung Cancer
EGFR, ALK, RET, KRAS and BRAF alterations in never-smokers with non-small cell lung cancer
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors | Science Translational Medicine
Personalized medicine and inhibition of EGFR signaling in lung cancer. | Semantic Scholar
Mining whole-lung information by artificial intelligence for predicting EGFR genotype and targeted therapy response in lung cancer: a multicohort study - The Lancet Digital Health
A favourable prognostic marker for EGFR mutant non-small cell lung cancer: immunohistochemical analysis of MUC5B | BMJ Open
Cancers | Free Full-Text | EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance
Frontiers | Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current Challenges and New Strategies
Lung cancer - The Lancet
The biology of EGFR mutations in lung cancer. In normal cells, binding... | Download Scientific Diagram
Genomic signatures define three subtypes of EGFR-mutant stage II–III non-small-cell lung cancer with distinct adjuvant therapy outcomes | Nature Communications
Nanoscale Mapping of EGFR and c-MET Protein Environments on Lung Cancer Cell Surfaces via Therapeutic Antibody Photocatalyst Conjugates | ACS Chemical Biology
Cancers | Free Full-Text | Intrinsic Resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance
Cancer Cytopathology on Twitter: "Data reveals cell-free DNA can be extracted from lung cancer FNA supernatants for EGFR mutation analysis, an important marker for targeted therapy in patients with advanced lung cancer.
Multiplicity of EGFR and KRAS Mutations in Non-small Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors | Anticancer Research
Coregulation of pathways in lung cancer patients with EGFR mutation: therapeutic opportunities | British Journal of Cancer
EGFR and Lung Cancer | American Lung Association
The role of HGF-MET pathway and CCDC66 cirRNA expression in EGFR resistance and epithelial-to-mesenchymal transition of lung adenocarcinoma cells | Journal of Hematology & Oncology | Full Text
Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression | Scientific Reports
